BACKGROUND AND OBJECTIVE: Among patients with Brugada syndrome (BS) and aborted cardiac arrest, syncope, or inducible ventricular fibrillation at electrophysiologic study (EPS), the only currently recommended therapy is an implantable cardioverter-defibrillator (ICD), but these are not without complications. We assessed the total number of shocks (appropriate and inappropriate) and complications related to ICD in patients with BS. METHODS AND RESULTS: Twenty-five patients implanted with ICD for BS in 6 Gulf centers between January 1, 2002, and December 31, 2010, were reviewed. Implantable cardioverter-defibrillator indication was based on aborted cardiac arrest (24%), syncope (56%), or in asymptomatic patients with positive EPS (20%). During a follow-up of 41.2 ± 17.6 months, 3 patients (all with prior cardiac arrest) had appropriate device therapy. Four patients developed complications; 3 of them had inappropriate shocks. CONCLUSION: In our cohort, appropriate device therapy was limited to cardiac arrest survivors, whereas none of those with syncope and/or positive EPS had arrhythmias. Overall complication rate was relatively high, including inappropriate ICD shocks.
BACKGROUND AND OBJECTIVE: Among patients with Brugada syndrome (BS) and aborted cardiac arrest, syncope, or inducible ventricular fibrillation at electrophysiologic study (EPS), the only currently recommended therapy is an implantable cardioverter-defibrillator (ICD), but these are not without complications. We assessed the total number of shocks (appropriate and inappropriate) and complications related to ICD in patients with BS. METHODS AND RESULTS: Twenty-five patients implanted with ICD for BS in 6 Gulf centers between January 1, 2002, and December 31, 2010, were reviewed. Implantable cardioverter-defibrillator indication was based on aborted cardiac arrest (24%), syncope (56%), or in asymptomatic patients with positive EPS (20%). During a follow-up of 41.2 ± 17.6 months, 3 patients (all with prior cardiac arrest) had appropriate device therapy. Four patients developed complications; 3 of them had inappropriate shocks. CONCLUSION: In our cohort, appropriate device therapy was limited to cardiac arrest survivors, whereas none of those with syncope and/or positive EPS had arrhythmias. Overall complication rate was relatively high, including inappropriate ICD shocks.
Authors: Alawi A Alsheikh-Ali; Ahmad S Hersi; Adel K S Hamad; Ahmed R Al Fagih; Faisal M Al-Samadi; Abdulmohsen M Almusaad; Fayez A Bokhari; Fawzia Al-Kandari; Bandar S Al-Ghamdi; Najib Al Rawahi; Nidal Asaad; Salem Alkaabi; Amin Daoulah; Hosam A Zaky; Omer Elhag; Yahya S Al Hebaishi; Raed Sweidan; Haitham Alanazi; David Chase; Hani Sabbour; Mohammad Al Meheiri; Ismail Al Abri; Mohammad Amin; Khaled Dagriri; Adil O Ahmed; Azam Shafquat; Shahul Hameed Khan Journal: Heart Views Date: 2015 Oct-Dec
Authors: Ahmed Bayoumy; Meng-Qi Gong; Ka Hou Christien Li; Sunny Hei Wong; William Kk Wu; Guang-Ping Li; George Bazoukis; Konstantinos P Letsas; Wing Tak Wong; Yun-Long Xia; Tong Liu; Gary Tse Journal: J Geriatr Cardiol Date: 2017-10 Impact factor: 3.327